Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 12-May 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 80036701000001114 | Eptotermin alfa (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 80036801000001117 | Eptotermin alfa | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eptotermin alfa | Is a | Recombinant human bone morphogenetic protein 7 | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Eptotermin alfa 3.3mg powder for implantation suspension vials | Has specific active ingredient | False | Eptotermin alfa | Inferred relationship | Existential restriction modifier | |
| Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) | Has specific active ingredient | False | Eptotermin alfa | Inferred relationship | Existential restriction modifier | |
| Eptotermin alfa 3.3mg powder for implantation suspension vials 1 vial | Has specific active ingredient | False | Eptotermin alfa | Inferred relationship | Existential restriction modifier | |
| Osigraft 3.3mg powder for implantation suspension vials (Olympus Biotech UK Ltd) 1 vial | Has specific active ingredient | False | Eptotermin alfa | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR